Diatx Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 16-11-2024
- Paid Up Capital ₹ 0.10 M
as on 16-11-2024
- Company Age 5 Year, 10 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -22.32%
(FY 2023)
- Profit -55.83%
(FY 2023)
- Ebitda -47.01%
(FY 2023)
- Net Worth 19.65%
(FY 2023)
- Total Assets -33.99%
(FY 2023)
About Diatx Biotech
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Suryakant Shukla and Anil Singh serve as directors at the Company.
- CIN/LLPIN
U33110MH2019PTC321420
- Company No.
321420
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
19 Feb 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Diatx Biotech Private Limited offer?
Diatx Biotech Private Limited offers a wide range of products and services, including TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Nutraceuticals & Dietary Supplements, Fitness Supplements, Cardiovascular Drugs & Medication, Kidney Drugs.
Who are the key members and board of directors at Diatx Biotech?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suryakant Shukla  | Director | 08-Apr-2019 | Current |
| Anil Singh | Director | 19-Feb-2019 | Current |
Financial Performance of Diatx Biotech.
Diatx Biotech Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 22.32% decrease. The company also saw a substantial fall in profitability, with a 55.83% decrease in profit. The company's net worth Soared by an impressive increase of 19.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Diatx Biotech?
In 2023, Diatx Biotech had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Diatx Biotech?
Unlock and access historical data on people associated with Diatx Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Diatx Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Diatx Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
